SAN DIEGO, April 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma's registration statement issued in connection with Zenas...
Read More Details
Finally We wish PressBee provided you with enough information of ( ZBIO INVESTOR ALERT: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Lou Christie, “Lightnin’ Strikes” and “Rhapsody in the Rain” Singer, Dies at 82
- Detained Afghan’s legal entry into U.S. was ‘improvident,’ government argues
- Legendary '80s Metal Band Performs Fan-Favorite for First Time in 20 Years: 'Sounding Great'